Magwate, Rayza L.

HRN: 22-45-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFUROXIME 750MG (VIAL)
01/03/2023
01/10/2023
IV
370mg
Q8
URTI; Severe Anemia
Waiting Final Action 
01/04/2023
CEFTRIAXONE 1G (VIAL)
01/04/2023
01/10/2023
IVT
1g
OD
Urti; Anemia
Waiting Final Action 
01/05/2023
OXACILLIN 500MG (VIAL)
01/05/2023
01/12/2023
IV
275mg
Q6hours
URTI; Anemia, Severe
Waiting Final Action 
01/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2023
01/14/2023
IV
1g
Q6hours
URTI; Severe Anemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: